Milestone Scientific Inc
Change company Symbol lookup
Select an option...
MLSS Milestone Scientific Inc
BAC Bank of America Corp
IMKTA Ingles Markets Inc
III Information Services Group Inc
HVRRY Hannover Rueck SE
HVRRF Hannover Rueck SE
HNFSB Hanover Foods Corp
HNFSA Hanover Foods Corp
HJLI Hancock Jaffe Laboratories Inc
HHSE Hannover House Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap BlendCompany profile

Milestone Scientific Inc. (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types. Milestone's product portfolio includes Single Tooth Anesthesia Instrument (STA Instrument), CompuDent, CompuMed and The Wand. The Company's STA Instrument is a computer-controlled local anesthesia delivery instrument that utilizes the pressure feedback elements of Milestone's CompuFlo technology. CompuDent (also known as the Wand Plus internationally) is Milestone's C-CLAD instrument. CompuMed is a computer-controlled injection instrument offered by the Company. The Wand handpiece is used in conjunction with the STA, CompuDent and CompuMed instruments.

Closing Price
$1.16
Day's Change
-0.10 (-7.94%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.28
Day's Low
1.12
Volume
(Heavy Day)
Volume:
581,844

10-day average volume:
357,643
581,844

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ADTRAN, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

12:47 pm ET October 9, 2019 (BusinessWire) Print

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADTRAN, Inc. ("ADTRAN" or "the Company") (NASDAQ: ADTN) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. ADTRAN announced "preliminary" earnings for the second quarter of 2019 on July 17, 2019. This was due to the Company's ongoing assessment of excess and obsolete inventory reserves ("E&O reserves"). On August 12, 2019, ADTRAN indicated that it would be incapable of filing its quarterly financial report with the SEC in a timely manner due to a material weakness related to E&O reserves.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191009005643/en/

SOURCE: The Schall Law Firm

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com 
www.schallfirm.com

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.